The estimated number of PWID ranges from 104,804 to 420,000 PWID. HIV prevalence in this population is above 40 % in several cities, including Faisalabad (52.5 %), D.G. Khan (49.6 %), Gujrat (46.2 %), Karachi (42.2 %) and Sargodha (40.6 %), respectively. Harm reduction service delivery is being implemented through a public-private partnership led by the National and Provincial AIDS Control Programmes and Nai Zindagi with funding support from the Global Fund. Current programmatic coverage of the needle and syringe programme, HIV testing and counselling and antiretroviral treatment among PWID remain insufficient to control ongoing transmission of HIV in the country.
While opioid substitution therapy (OST) is yet to be introduced, significant progress and coordination among various ministries have taken place recently to register buprenorphine in the dosage required for treatment of opioid dependence, and possible introduction of OST will greatly facilitate adherence to antiretroviral treatment among PWID living with HIV.
Full article
at: http://goo.gl/Qu22bC
By: Anne
Bergenstrom1*, Baseer
Achakzai2, Sofia
Furqan2, Manzoor
ul Haq3, Rajwal
Khan4and Marc
Saba4
1United Nations Office
of Drugs and Crime (UNODC), Plot 5-11, Diplomatic Enclave-II, G-4, Islamabad
44000, Pakistan
2National AIDS Control
Programme, National Institute of Health, Chak Shahzad, Park Road, Islamabad
44000, Pakistan
3United Nations Office
of Drugs and Crime (UNODC), Plot 5-11, Diplomatic Enclave-II, G-4, Islamabad
44000, Pakistan
4UNAIDS Country Office
for Pakistan & Afghanistan, Level-5, Serena Business Complex,
Khyaban-e-Suhrwardy, Islamabad, Pakistan
More at: https://twitter.com/hiv_insight
No comments:
Post a Comment